Biotics Research Corporation

04/28/2026

Meet Our Speakers - Greg Jones, ND, ABAAHP

Speaker Topic: Peptides and Precision Supplementation: Using Targeted Nutritional Support to Amplify Longevity, Repair, and Metabolic Health

Peptide therapy has emerged as an effective intervention for improving metabolic health, cognitive function, physical performance, gut integrity, and tissue repair. However, patient response and long-term success are strongly influenced by underlying nutritional status, inflammatory burden, and metabolic resilience. This session explores how targeted supplement strategies can enhance peptide signaling, improve clinical outcomes, and support sustainable results.
Through clinical case studies and Biotics Research product–focused insights, attendees will learn how to pair peptide therapies with evidence-based nutritional support to optimize mitochondrial function, hormonal signaling, gut health, cognition, and recovery. The presentation will also address supplement-based alternatives for patients who are non-responsive to peptides or hesitant to initiate injectable therapy, providing clinicians with practical, flexible tools for personalized longevity care.

https://hubs.la/Q04dJt_g0

04/23/2026

As GLP-1 and dual GIP/GLP-1 weight-loss medications continue to rise in popularity, emerging research highlights an important consideration: nutritional status.

While these therapies offer significant benefits, studies suggest they may also be associated with micronutrient deficiencies, loss of lean muscle mass, and long-term reliance due to weight rebound after discontinuation.

The takeaway? Medication alone isn’t enough. A comprehensive approach—including targeted nutrition, resistance training, and behavioral support—is essential to optimize outcomes and minimize risks.

Key Callouts:
* 1 in 8 U.S. adults is currently using anti-obesity medications (AOMs)
* Discontinuation may lead to 60–163% weight regain and worsening metabolic markers
* Common deficiencies: vitamin D, B12, iron, calcium, magnesium, fiber, and protein
* Up to 30–40% of weight lost may come from lean muscle mass
* Reduced “food noise” presents an opportunity to improve long-term dietary habits
* Resistance training + adequate protein intake are critical to preserve muscle and bone health
* Structured nutrition + lifestyle interventions should be standard alongside medication

https://hubs.la/Q04ddrxj0

04/22/2026

Meet Our Speakers - Lindsey Berkson, MA, DC, CNS, DACBN

Speaker Topic: Turning Back the Aging Clock: Evidence-Based Strategies to Measure and Influence Biological Age

In this seminar, you'll learn how to accurately track the aging process and determine whether your interventions are truly making an impact. We will explore how markers such as FSH provide a ticker-tape readout of biological aging- and how targeted strategies can help shift those markers towards a more youthful profile.

https://hubs.la/Q04cTn650

04/21/2026

A recent study published in Frontiers in Psychiatry explored a pilot program designed to support individuals who self-identify with ultra-processed food addiction (UPFA).

While UPFA isn’t formally recognized as a diagnosis, it may impact up to 20% of the population—and even more among those with disordered eating patterns or metabolic conditions. This 6-week, coach-led program combined nutrition education, behavior change strategies, and peer support, using both abstinence and harm-reduction approaches.

The results? Meaningful improvements in addictive eating behaviors and mental well-being—sustained even 6 months later.

Key Takeaways:
• Ultra-processed food addiction may require a different approach than “moderation” alone
• Education + peer support can significantly improve behavior and mindset
• Participants reported less impulsive eating and greater self-awareness
• Mental well-being improved alongside eating behaviors
• Weight changes were modest, highlighting that behavior change goes beyond the scale
• Reframing UPFA as a disease may reduce shame and support long-term success

A study in Frontiers in Psychiatry describes the results from a pilot program testing the feasibility and acceptability of an online, peer-supported intervention for adults self-identifying with ultra-processed food addiction (UPFA).

04/16/2026

Wellness Unfiltered Pro - From Adaptogens to Hormones: A Structured Approach to Adrenal Support

In this episode, we break down adrenal health through the lens of the HPA axis, moving beyond simplistic “adrenal fatigue” models. You’ll learn how to differentiate when to use adaptogens, glandulars, and hormone precursors based on patient presentation, physiology, and lab patterns. This structured approach helps clinicians move from symptom-based protocols to true neuroendocrine restoration. If your patients aren’t responding to adrenal support, this conversation will show you why and what to do next.
https://hubs.la/Q04cmDq70

04/15/2026

Ketogenic and very-low-carbohydrate diets are increasingly supported in the literature for applications beyond weight management, including metabolic health, mental health, and chronic disease management. Despite persistent misconceptions, several conditions often considered contraindications may not preclude the use of a ketogenic approach. When appropriately individualized and medically supervised, ketogenic diets can be implemented safely across diverse patient populations.

Key Clinical Takeaways:
* Macronutrient composition: Ketogenic diets are defined by carbohydrate restriction, not high protein intake; both protein and fat can be individualized based on clinical needs.
* Chronic kidney disease (CKD): Emerging evidence suggests potential for slowing disease progression and improving renal markers, though monitoring is essential.
* Type 1 diabetes: Carbohydrate restriction may improve glycemic control and reduce insulin requirements, but requires careful medical oversight to mitigate risk.
* Post-cholecystectomy: Patients may tolerate ketogenic diets with tailored fat intake and digestive support as needed.
* Eating disorders: Preliminary data and case reports suggest potential benefits in reducing binge eating behaviors and improving psychological outcomes.
* Plant-based approaches: Ketogenic diets can be adapted to vegetarian or vegan frameworks with appropriate nutrient planning.
* Dairy intolerance: Dairy is not required; adequate macro- and micronutrient intake can be achieved through alternative sources.
* Medication considerations: Close monitoring is critical, as medications such as insulin, antihypertensives, and SGLT2 inhibitors often require rapid adjustment.

https://hubs.la/Q04c7yWH0

04/10/2026

Recent findings published in BMJ highlight an interesting comparison between tai chi and cognitive behavioral therapy for insomnia (CBT-I) in managing chronic insomnia.

While CBT-I remains the gold standard for short-term improvement, this randomized controlled trial suggests that tai chi may offer comparable long-term benefits—positioning it as a viable, non-pharmacologic option for sustained sleep support.

Key takeaways:
* CBT-I showed greater improvements in insomnia severity at 3 months
* By 15 months, tai chi outcomes were comparable (non-inferior) to CBT-I
* Insomnia remission rates followed a similar pattern—favoring CBT-I early, but equalizing over time
* Participants completed structured, instructor-led sessions for both interventions over 3 months
* Findings support tai chi as an effective long-term strategy for chronic insomnia management

https://hubs.la/Q04bl-_40

04/08/2026

Introducing Bio-DK Caps 10,000 IU™, the newest addition to our Vitamin D That Delivers™ family. It’s built on the same emulsification technology Biotics Research pioneered in 1975 — now in a high-potency 10,000 IU capsule with vitamins K1 and K2 (MK-7). Our emulsification technology disperses vitamin D into microscopic particles, delivering 200%+ greater bioavailability through preferential lymphatic absorption.

Complete D+K Synergy
Bio-DK Caps 10,000IU™ pairs high-dose D3 with both K1 and K2 as MK-7 for comprehensive vitamin K support. K1 serves as a biosynthetic precursor that your patients’ tissues convert into MK-4, while K2 as MK-7 directly activates the vitamin K-dependent proteins that guide calcium into bone and away from arterial walls. Together, they ensure the calcium your patients absorb goes where it belongs.

https://hubs.la/Q049_-rc0

04/06/2026

A recent review published in Clinical Obesity evaluates the risk of nutritional deficiencies associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide, liraglutide, and tirzepatide.

Drawing from six adult studies (n ≈ 500,000), the findings suggest that while these therapies are effective for weight reduction, they may also be associated with clinically relevant micronutrient insufficiencies and changes in body composition.

Key Findings:
• Vitamin D deficiency was the most prevalent, increasing from 7.5% at 6 months to 13.6% at 12 months, with average intake at ~20% of recommended levels
• Ferritin levels were 26–30% lower compared to individuals using SGLT2 inhibitors (e.g., empagliflozin, canagliflozin)
• More than 60% of participants reported inadequate intake of iron and calcium
• Deficiencies in vitamins B1 (thiamine) and B12 increased over time
• Approximately 30–40% of total weight loss may be attributable to loss of fat-free mass (lean tissue), potentially linked to insufficient protein and calcium intake

A recently published review in Clinical Obesity discusses the evidence for increased nutritional deficiencies associated with the use of Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide, liraglutide, and tirzepatide (a dual GIP/GLP-1RA receptor agonist). A search of PubMed...

04/02/2026

De-Stress Peptides™ delivers 150 mg of casein hydrolysate per capsule, providing the bioactive decapeptide alpha-casozepine — a clinically studied peptide. This peptide selectively binds to the benzodiazepine site of the GABA-A receptor, helping to promote calm, restful sleep and support a healthy stress response—without sedation, habituation, or dependency.*

Key Product Highlights:
• Supports a calm, relaxed state without sedation or cognitive impairment*
• Promotes healthy sleep onset and overall sleep quality*
• Helps modulate cortisol and support HPA axis balance*
• Non-habit forming with no withdrawal or dependency risk
• Well tolerated and safe for long-term daily use

Use code "DESTRESS10" for 10% off your next order
https://hubs.la/Q049x67T0

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

04/01/2026

Testosterone reflects the integrated function of neuroendocrine, circadian, and metabolic systems—serving as a clinical marker of overall physiological resilience.
Disruptions in stress response, sleep architecture, and metabolic balance can alter hormonal signaling, creating feedback loops that impact testosterone production, bioavailability, and downstream effects.

Key Clinical Insights:
* Chronic stress → elevated cortisol → suppression of HPG axis signaling, reducing testosterone over time
* Sleep restriction (e.g., ~5 hours/night) can decrease testosterone by 10–15%, with effects comparable to accelerated aging
* Testosterone, cortisol, and sleep operate within a bidirectional feedback loop influencing mood, recovery, and endocrine stability
* Mitochondrial function and oxidative stress are critical for steroidogenesis, with ROS impairing enzyme activity and androgen signaling
* The gut–brain–gonadal axis plays a role in hormone regulation, with microbiome balance influencing inflammation, metabolism, and androgen availability

Testosterone reflects the integrated function of neuroendocrine, circadian, and metabolic systems. Its regulation is embedded within a coordinated network linking stress physiology, sleep architecture, and environmental inputs.

03/25/2026

For decades, saturated fat has been labeled a key driver of cardiovascular disease—but newer research continues to challenge how strong that connection really is.

A recent large review suggests the impact of reducing saturated fat on heart health outcomes may be smaller (and less certain) than once believed.

Key takeaways:
* Evidence linking saturated fat reduction to lower mortality or cardiovascular events is low to moderate—and not statistically significant
* For individuals at low cardiovascular risk, reducing saturated fat shows little to no measurable benefit
* Replacing saturated fat with polyunsaturated fat shows only modest, uncertain improvements
* Refined carbohydrates may be a bigger concern—linked to worse lipid profiles and metabolic health
* Conditions like type 2 diabetes, insulin resistance, and metabolic syndrome appear to be stronger predictors of heart disease risk
* Whole foods containing saturated fat (like dairy or unprocessed meats) may offer nutritional benefits beyond fat content

Bottom line:
Heart health is complex—and focusing on overall diet quality and metabolic health may matter more than targeting saturated fat alone.
https://hubs.la/Q048b4S50